Do you drink too much? Change in belly may be early telltale sign of fatty liver disease
One expert has identified symptoms to spot that might indicate the beginning of liver damage - signs that can be hard to detect. (Source: Daily Express - Health)
Source: Daily Express - Health - September 19, 2022 Category: Consumer Health News Source Type: news

COVID-19 Severity and Mortality Among Liver Disease Patients COVID-19 Severity and Mortality Among Liver Disease Patients
How has chronic liver disease impacted severity of disease and death among COVID-19 patients?Preventing Chronic Disease (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 15, 2022 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Having problems talking? Slurred speech can signal severe stage of fatty liver disease
When fatty liver disease progresses to its most severe stage, also known as cirrhosis, it can have an impact across the body - including on your voice. (Source: Daily Express - Health)
Source: Daily Express - Health - September 14, 2022 Category: Consumer Health News Source Type: news

'Fatty liver' drug trial data sends Peninsula biotech's stock soaring more than 100%
With more than 17 million Americans with NASH, the fatty liver disease has been a prime target for drug developers. But few have been able to show promising clinical trial results. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 13, 2022 Category: American Health Authors: Ron Leuty Source Type: news

Bain, others invest in Nimbus Therapeutics' $125M round. Here's what the CEO had to say.
Nimbus Therapeutics last made headlines in 2016, when the Cambridge-based company sold a drug for the liver disease NASH to Gilead Sciences (Nasdaq: GILD) for a clean $1.2 billion — including $400 million up front. Since then, the company has quietly shifted its focus to autoimmune disease drugs, targeting the skin disorder psoriasis and certain cancers. Nimbus got a boost to those efforts on Monday. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 12, 2022 Category: American Health Authors: Rowan Walrath Source Type: news

Fatty liver disease symptom that appears just under the skin could signal liver scarring
THE LIVER is one of our vital organs that if not properly cared for can have potentially dangerous results. Fatty liver disease - also known as non-alcoholic fatty liver disease - refers to a range of liver conditions that are not linked to alcohol. It is caused by a build-up of fat in the liver. (Source: Daily Express - Health)
Source: Daily Express - Health - September 5, 2022 Category: Consumer Health News Source Type: news

Living-Donor Liver Transplant Tied to Substantial Survival Benefit Living-Donor Liver Transplant Tied to Substantial Survival Benefit
The benefit was even significant at Model for End-Stage Liver Disease-Sodium scores as low as 11.MDedge News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - September 2, 2022 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

Exposure to antibacterial chemical via lactation linked to liver damage in newborn mice
<div class="rxbodyfield">New NIEHS-funded study sheds light on how triclosan exposure can lead to liver disease, reveals potential health-protective interventions.</div> (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - September 2, 2022 Category: Environmental Health Source Type: news

SGLT2 Inhibitors Lower NAFLD, HCC Risks Over DPP4i SGLT2 Inhibitors Lower NAFLD, HCC Risks Over DPP4i
Sodium glucose cotransporter 2 inhibitors (SGLT2is) lowered the risk of nonalcoholic fatty liver disease and hapatocellular carcinoma versus dipeptidyl-peptidase-4 inhibitors (DPP4is).First Look (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - September 1, 2022 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Fatty liver disease: Sign in your vomit that could signal most severe stage of disease
FATTY liver disease, which is also known as non-alcoholic fatty liver disease, refers to a range of liver conditions that are not linked to alcohol. It is caused by a build-up of fat in the liver. If not caught early enough it can lead to potentially fatal liver failure. (Source: Daily Express - Health)
Source: Daily Express - Health - August 31, 2022 Category: Consumer Health News Source Type: news

U.S. Life Expectancy Declined Nearly a Year in 2021, Deepening Historic Slide
Americans’ life expectancy continued to slide in 2021. According to provisional data from the National Center for Health Statistics released on Aug. 31, life expectancy dropped by 0.9 years in 2021, leading to a total decrease of about 2.7 years between 2019 and 2021—the largest two-year decline in a century. Once again, COVID-19 was the primary reason Americans died younger, accounting for 50% of the decline. However, other causes of death—including drug overdoses, heart disease, and liver disease—also surged, hinting at the devastating ripple effects the pandemic has had on society. The life expec...
Source: TIME: Health - August 31, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Liver disease: The 'early' warning sign in your poo - 'Tell your doctor'
WHETHER you have a glass of wine with your dinner or reach for an ice-cold fruity cocktail on holiday, most people enjoy a drink from time to time. However, the problems occur when you regularly drink to excess as this can cause alcohol-related liver disease. Fortunately, there's one "early" sign that could ring alarm bells. (Source: Daily Express - Health)
Source: Daily Express - Health - August 30, 2022 Category: Consumer Health News Source Type: news

Is 'Juliet' Unwittingly Poisoned in Today's Environment?
(MedPage Today) -- What could connect such disquieting and disparate health concerns as early onset puberty, female depression, and fatty liver disease? Endocrine disrupting chemicals (EDCs) are leading candidates for all of these health aberrations... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 27, 2022 Category: American Health Source Type: news

COVID-19 Severity and Mortality Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - August 25, 2022 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Psilocybin May Help Treat Alcohol Addiction, Study Shows
By the time Jon Kostas was 25, he was desperate to beat his alcohol addiction. He had started drinking at age 13 and had cycled through different treatments—going to Alcoholics Anonymous meetings, taking pharmaceutical medications, and trying in-patient rehab—but nothing worked. Ever since 2015, however, when he took part in a clinical trial that combined talk therapy and psilocybin—the psychedelic active ingredient in magic mushrooms—Kostas has quit drinking. “I’m forever grateful and indebted,” he says. “This saved my life.” A randomized clinical trial, published Aug....
Source: TIME: Health - August 24, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized Addiction healthscienceclimate Source Type: news